HK1250375A1 - 病毒過濾 - Google Patents

病毒過濾

Info

Publication number
HK1250375A1
HK1250375A1 HK18109831.4A HK18109831A HK1250375A1 HK 1250375 A1 HK1250375 A1 HK 1250375A1 HK 18109831 A HK18109831 A HK 18109831A HK 1250375 A1 HK1250375 A1 HK 1250375A1
Authority
HK
Hong Kong
Prior art keywords
virus filtration
virus
filtration
Prior art date
Application number
HK18109831.4A
Other languages
English (en)
Inventor
Bianca Olson
Saravanamoorthy Rajendran
Ryan Tedstone
Original Assignee
Alexion Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alexion Pharma Inc filed Critical Alexion Pharma Inc
Publication of HK1250375A1 publication Critical patent/HK1250375A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58—Multistep processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/08—Hollow fibre membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/08—Polysaccharides
    • B01D71/10—Cellulose; Modified cellulose
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/30—Polyalkenyl halides
    • B01D71/32—Polyalkenyl halides containing fluorine atoms
    • B01D71/34—Polyvinylidene fluoride
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/56—Polyamides, e.g. polyester-amides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06—Organic material
    • B01D71/66—Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
    • B01D71/68—Polysulfones; Polyethersulfones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/18—Details relating to membrane separation process operations and control pH control
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • External Artificial Organs (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK18109831.4A 2015-03-23 2018-07-31 病毒過濾 HK1250375A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562137187P 2015-03-23 2015-03-23
PCT/US2016/023746 WO2016154290A1 (en) 2015-03-23 2016-03-23 Virus filtration

Publications (1)

Publication Number Publication Date
HK1250375A1 true HK1250375A1 (zh) 2018-12-14

Family

ID=55752716

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18109831.4A HK1250375A1 (zh) 2015-03-23 2018-07-31 病毒過濾

Country Status (6)

Country Link
US (2) US20180072769A1 (zh)
EP (1) EP3274359B1 (zh)
JP (2) JP7133925B2 (zh)
ES (1) ES2936088T3 (zh)
HK (1) HK1250375A1 (zh)
WO (1) WO2016154290A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180072769A1 (en) 2015-03-23 2018-03-15 Alexion Pharmaceuticals, Inc. Virus filtration
SG11201911877RA (en) * 2017-06-12 2020-01-30 Asahi Kasei Medical Co Ltd Method for filtering protein-containing liquid
US11802154B2 (en) 2017-12-20 2023-10-31 Alexion Pharmaceuticals, Inc. Humanized anti-CD200 antibodies and uses thereof
CN115397834A (zh) * 2020-04-13 2022-11-25 3M创新有限公司 用于纯化目标分子的流通方法和装置
WO2022186240A1 (ja) * 2021-03-03 2022-09-09 テルモ株式会社 サンプリング方法
JP2022174217A (ja) * 2022-09-12 2022-11-22 旭化成メディカル株式会社 抗体の精製方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
WO1996003202A1 (en) 1994-07-28 1996-02-08 Millipore Corporation Porous composite membrane and process
US6365395B1 (en) 2000-11-03 2002-04-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
DK2359834T5 (en) 2006-03-15 2017-02-06 Alexion Pharma Inc Treatment of paroxysmal nocturnal hemoglobinuria patients with a complement inhibitor
EP2069387A4 (en) 2006-06-14 2011-02-02 Glaxosmithkline Llc METHODS OF PURIFYING ANTIBODIES USING HYDROXYAPATITE CERAMIC
JP2011184299A (ja) 2008-07-02 2011-09-22 Asahi Kasei Medical Co Ltd モノクローナル抗体を含む製剤の製造方法
EP2412817B2 (en) * 2009-03-27 2019-06-05 Asahi Kasei Medical Co., Ltd. Method for removing viruses in high-concentration monoclonal antibody solution
WO2010127069A1 (en) * 2009-04-29 2010-11-04 Schering Corporation Antibody purification
KR101844859B1 (ko) 2009-08-06 2018-05-18 제넨테크, 인크. 단백질 정제 시의 바이러스 제거의 개선방법
TWI803876B (zh) 2011-03-28 2023-06-01 法商賽諾菲公司 具有交叉結合區定向之雙重可變區類抗體結合蛋白
JP6055615B2 (ja) * 2011-05-27 2016-12-27 アッヴィ バイオテクノロジー リミテッド Ｄａｃｈｙｐ組成物および方法
ES2641042T3 (es) 2011-06-24 2017-11-07 Asahi Kasei Kuraray Medical Co., Ltd. Procedimiento para la fabricación de un fármaco proteínico
DE102011105525B4 (de) 2011-06-24 2015-03-26 Sartorius Stedim Biotech Gmbh Verfahren zur Abtrennung von Biopolymer-Aggregaten und Viren aus einem Fluid
AU2013262083A1 (en) 2012-05-14 2014-11-06 Novo Nordisk A/S Stabilised protein solutions
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
AU2013277532B2 (en) * 2012-06-21 2017-06-15 Takeda Pharmaceutical Company Limited Virus filtration of cell culture media
NZ631007A (en) 2014-03-07 2015-10-30 Alexion Pharma Inc Anti-c5 antibodies having improved pharmacokinetics
FR3025515B1 (fr) * 2014-09-05 2016-09-09 Lab Francais Du Fractionnement Procede de purification d'un anticorps monoclonal
US20180072769A1 (en) 2015-03-23 2018-03-15 Alexion Pharmaceuticals, Inc. Virus filtration

Also Published As

Publication number Publication date
JP7133925B2 (ja) 2022-09-09
JP2022058979A (ja) 2022-04-12
US20220332755A1 (en) 2022-10-20
US20180072769A1 (en) 2018-03-15
EP3274359A1 (en) 2018-01-31
JP7475381B2 (ja) 2024-04-26
ES2936088T3 (es) 2023-03-14
WO2016154290A1 (en) 2016-09-29
US11919925B2 (en) 2024-03-05
EP3274359B1 (en) 2022-11-02
JP2018510166A (ja) 2018-04-12

Similar Documents

Publication Publication Date Title
EP3393506C0 (en) VIRUS PURIFICATION PROCESS
IL259540A (en) variable filter
GB201619763D0 (en) Filter
GB201406608D0 (en) Virus
SG10201604853WA (en) Filter assembly
HK1250375A1 (zh) 病毒過濾
IL267785A (en) virus
ZA201802086B (en) Filtering syringe
SG11201608231SA (en) Filter
HK1259335A1 (zh) 過濾注射器
SG10201600195VA (en) Filter elements
GB2554297B (en) Self-cleaning filter
GB201419572D0 (en) Virus
PL3296006T3 (pl) Filtr
TWI562536B (en) Common mode filter
GB201614241D0 (en) Filter
GB2548659B (en) Filter
TWI561259B (en) Filter
GB201603612D0 (en) Filter
GB201601242D0 (en) Filter
SG11201609908VA (en) Virus reduction method
GB201700232D0 (en) Filter
GB201615838D0 (en) Strainers
GB2543480B (en) Filtration mask
GB201716047D0 (en) Virus